EXoZymes, Inc.
EXOZ
Rank in Stocks
#24199
eXoZymes, Inc. operates as a development stage biotechnology company. It... eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Share Price
$4.00
Last synced: 2026-11-12
Market Cap
$34.64M
Change (1 day)
0.00%
Change (1 year)
-73.79%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade EXoZymes, Inc. (EXOZ)
Category
Healthcare
EPS for EXoZymes, Inc. (EXOZ)
EPS as of June 2026 TTM: $-1.20
According to EXoZymes, Inc.'s latest financial reports, its current EPS (TTM) is $-1.20. At the end of 2025 the company had an EPS of $-1.09, a decrease compared to its 2024 EPS of $-0.72.
EPS history for EXoZymes, Inc. from 2021 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.20 | 10.09% |
| 2025 | $-1.09 | 51.39% |
| 2024 | $-0.72 | 188.00% |
| 2023 | $-0.25 | 47.06% |
| 2022 | $-0.17 | 13.33% |
| 2021 | $-0.15 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.99 | -17.50% |
US
|
|
| $15.66 | -1,405.00% |
US
|
|
| $-7.07 | 489.17% |
US
|
|
| $-5.29 | 340.83% |
AU
|
|
| $12.88 | -1,173.34% |
BE
|
Questions about EXoZymes, Inc.'s earnings per share (EPS)
What is EXoZymes, Inc.'s earnings per share (EPS)?
EXoZymes, Inc.'s earnings per share (EPS) over the last twelve months is $-1.20, as of Jun 2026.
What was EXoZymes, Inc.'s earnings per share (EPS) in 2025?
In 2025, EXoZymes, Inc.'s earnings per share (EPS) was $-1.09, compared with $-0.72 in 2024.
How has EXoZymes, Inc.'s earnings per share (EPS) changed since 2021?
From 2021 to 2025, EXoZymes, Inc.'s earnings per share (EPS) was highest in 2021 ($-0.15) and lowest in 2025 ($-1.09).
How does EXoZymes, Inc.'s earnings per share (EPS) compare with similar companies?
EXoZymes, Inc.'s earnings per share (EPS) ($-1.20) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.